Horizon Discovery announces collaboration with major pharmaceutical company on single cell RNAseq-linked CRISPR screening
Location: Cambridge, UK 28/08/2018 Co-development and implementation of a new CRISPR-based screening technology platform to address critical gaps in target ID and validation Single cell RNAseq-linked pooled CRISPR screening offers unparalleled depth of screening data and biological insight New platform will further enhance Horizon’s CRISPR screening capabilities Cambridge, UK, 28 August 2018: Horizon Discovery Group... Read more